Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

Human Pathology

Volumn 31, Issue 11, 2000, Pages 1420-1424

  Werness, Bruce A ^a,b,c,d,e   Ramus, Susan J ^a,b,c,d   Whittemore, Alice S ^a,b,c,d   Garlinghouse Jones, Kim ^a,b,c,d   Oakley Girvan, Ingrid ^a,b,c,d   Dicioccio, Richard A ^a,b,c,d   Tsukada, Yoshiaki ^a,b,c,d   Ponder A J , Bruce ^a,b,c,d   Piver, M Steven ^a,b,c,d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d St Joseph Campus   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

BRCA1; Familial ovarian cancer; Ovarian neoplasms

Indexed keywords

DNA;

ARTICLE; CANCER GRADING; CANCER STAGING; DYSGERMINOMA; FAMILIAL CANCER; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE; OVARY TUMOR;

EID: 0033694786     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(00)80014-3     Document Type: Article

References (35)

1. Cancer Statistics, 2000
2. Contribution of BRCA 1 mutations to ovarian cancer
3. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA 1 or BRCA2 mutations and sporadic cases
4. Tumour biological features of BRCA1-induced breast and ovarian cancer
5. Mutations at BRCA1: The medullary breast carcinoma revisited
6. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study
7. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
8. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden
9. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
10. Characteristics of genetically determined ovarian cancer
11. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer
12. Histology of BRCA1-associated ovarian tumors
13. Clinical and genetic evaluation of thirty ovarian cancer families
14. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
15. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers: With emphasis on methodology
16. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma: Clinical implications
17. Characteristics of familial ovarian cancer: A report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry
18. Germline mutations in the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
19. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core
20. Histological Typing of Ovarian Tumours (ed 2)
21. Histologic classification of tumors of the ovary
22. International Federation of Gynecologists and Obstetricians: Changes in definitions of clinical staging for carcinoma of the cervix and ovary
23. Ovarian carcinoma in-situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53
24. Primary ovarian germ cell tumor in a patient with a germline BRCA1 mutation
25. Hereditary ovarian cancer: A clinicopathological study
26. Classification of surface epithelial neoplasms of the ovary
27. Differences between hereditary and sporadic ovarian cancer
28. Mullerian epithelial and mesenchymal tumors. Introduction, clinical perspective, and principles of management
29. Observer disagreement in histological classification of ovarian tumors in Japan
30. Sources of variability in classifying common ovarian cancers using the World Health Organization classification: Application of the pathtracking method
31. High frequency of BRCA 1 185delAG mutation in ovarian cancer in Israel
32. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer
33. Rates of Jewish ancestral mutations in BRCA 1 and BRCA2 in borderline ovarian tumors
34. BRCA 1 gene mutations in women with papillary serous carcinoma of the peritoneum
35. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening